Loomis, Sayles & Company
LAB icon

Loomis, Sayles & Company’s Standard BioTools LAB Stock Holding History

Loomis, Sayles & Company’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-13,016
Closed -$548K – 927
2015
Q1 		$548K Buy
+13,016
New +$515K ﹤0.01% 640
2014
Q2 		– Sell
-395,421
Closed -$17.4M – 767
2014
Q1 		$17.4M Sell
395,421
-84,744
-18% -$3.73M 0.05% 399
2013
Q4 		$18.4M Buy
+480,165
New +$14.1M 0.06% 380

Other funds holding LAB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Loomis, Sayles & Company's LAB Position: Q2 2015 in Review

Loomis, Sayles & Company sold out of Standard BioTools (LAB) in Q2 2015, closing a stake of 13,016 shares — an estimated $548K sold.

Loomis, Sayles & Company first reported a position in LAB in Q4 2013 and held it in 3 quarters. The position peaked at $18.4M in Q4 2013. 107 funds tracked by Wall St. Rank hold LAB as of Q2 2015.

  • Loomis, Sayles & Company reported no remaining Standard BioTools position as of Q2 2015 after selling out during the quarter.
  • Loomis, Sayles & Company sold 13,016 Standard BioTools shares in Q2 2015, an estimated $548K.
  • Loomis, Sayles & Company first reported a position in Standard BioTools in Q4 2013 and held it in 3 quarters.
  • Loomis, Sayles & Company's Standard BioTools position peaked at $18.4M in Q4 2013.
  • 107 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2015.

Based on Loomis, Sayles & Company's 13F filing for Q2 2015, filed 14 Aug 2015.